Cirmaker Technology Corporation
Cirmaker Technology Corporation engages in the manufacture, distribution, and assembling of various electronic parts and components for sale primarily in the Asian markets. It provides electronic terminals, electronic blocks and accessories, electronic panel control and locking components, power distribution blocks and accessories, electronic timer and relay sockets, optical fiber connectors and … Read more
Cirmaker Technology Corporation (CRKT) - Net Assets
Latest net assets as of September 2005: $4.20 Million USD
Based on the latest financial reports, Cirmaker Technology Corporation (CRKT) has net assets worth $4.20 Million USD as of September 2005.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.63 Million) and total liabilities ($12.43 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.20 Million |
| % of Total Assets | 25.27% |
| Annual Growth Rate | -12.94% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 8.72 |
Cirmaker Technology Corporation - Net Assets Trend (2001–2004)
This chart illustrates how Cirmaker Technology Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cirmaker Technology Corporation (2001–2004)
The table below shows the annual net assets of Cirmaker Technology Corporation from 2001 to 2004.
| Year | Net Assets | Change |
|---|---|---|
| 2004-12-31 | $4.76 Million | -24.73% |
| 2003-12-31 | $6.33 Million | -7.60% |
| 2002-12-31 | $6.85 Million | -5.13% |
| 2001-12-31 | $7.22 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cirmaker Technology Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1355.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2004)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $27.40K | 0.82% |
| Other Components | $7.39 Million | 221.67% |
| Total Equity | $3.33 Million | 100.00% |
Cirmaker Technology Corporation Competitors by Market Cap
The table below lists competitors of Cirmaker Technology Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Henderson European Focus Trust Plc
LSE:HET
|
$223.40 |
|
Henderson High Income Trust
LSE:HHI
|
$223.42 |
|
Engage XR Holdings PLC
LSE:EXR
|
$223.50 |
|
Blackrock North American Income Trust PLC
LSE:BRSA
|
$223.60 |
|
Canna Consumer Goods Inc
PINK:CBMJ
|
$222.48 |
|
Mendocino Brewing Company Inc
PINK:MENB
|
$222.28 |
|
HORN PETROLEUM
MU:H73
|
$222.08 |
|
iExalt Inc
OTCGREY:IEXA
|
$222.05 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cirmaker Technology Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2003 to 2004, total equity changed from 4,551,674 to 3,333,646, a change of -1,218,028 (-26.8%).
- Net loss of 2,417,884 reduced equity.
- Other factors increased equity by 1,199,856.
Equity Change Factors (2003 to 2004)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.42 Million | -72.53% |
| Other Changes | $1.20 Million | +35.99% |
| Total Change | $- | -26.76% |
Book Value vs Market Value Analysis
This analysis compares Cirmaker Technology Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Cirmaker Technology Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.53%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.57%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 5.42x
- Recent ROE (-72.53%) is below the historical average (-25.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -0.78% | -0.46% | 0.89x | 1.89x | $-778.13K |
| 2002 | 8.24% | 2.94% | 1.16x | 2.41x | $-120.83K |
| 2003 | -35.16% | -9.62% | 0.97x | 3.75x | $-2.06 Million |
| 2004 | -72.53% | -13.57% | 0.99x | 5.42x | $-2.75 Million |
Industry Comparison
This section compares Cirmaker Technology Corporation's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cirmaker Technology Corporation (CRKT) | $4.20 Million | -0.78% | 2.96x | $222.82 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |